General Information of Drug Off-Target (DOT) (ID: OTKELV1D)

DOT Name Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2)
Synonyms EC 1.14.11.-
Gene Name ASPHD2
UniProt ID
ASPH2_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
1.14.11.-
Pfam ID
PF05118
Sequence
MVWAPLGPPRTDCLTLLHTPSKDSPKMSLEWLVAWSWSLDGLRDCIATGIQSVRDCDTTA
VITVACLLVLFVWYCYHVGREQPRPYVSVNSLMQAADANGLQNGYVYCQSPECVRCTHNE
GLNQKLYHNLQEYAKRYSWSGMGRIHKGIREQGRYLNSRPSIQKPEVFFLPDLPTTPYFS
RDAQKHDVEVLERNFQTILCEFETLYKAFSNCSLPQGWKMNSTPSGEWFTFYLVNQGVCV
PRNCRKCPRTYRLLGSLRTCIGNNVFGNACISVLSPGTVITEHYGPTNIRIRCHLGLKTP
NGCELVVGGEPQCWAEGRCLLFDDSFLHAAFHEGSAEDGPRVVFMVDLWHPNVAAAERQA
LDFIFAPGR
Function May function as 2-oxoglutarate-dependent dioxygenase.

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
2 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [1]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene increases the methylation of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [7]
------------------------------------------------------------------------------------
8 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Ciclosporin DMAZJFX Approved Ciclosporin increases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [2]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [3]
Acetaminophen DMUIE76 Approved Acetaminophen increases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [4]
Temozolomide DMKECZD Approved Temozolomide increases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [5]
Zoledronate DMIXC7G Approved Zoledronate decreases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [6]
Trichostatin A DM9C8NX Investigative Trichostatin A decreases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [8]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [9]
Acetaldehyde DMJFKG4 Investigative Acetaldehyde increases the expression of Aspartate beta-hydroxylase domain-containing protein 2 (ASPHD2). [10]
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Drug(s)

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
3 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
4 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
5 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
6 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
7 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
8 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
9 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
10 Transcriptome profile analysis of saturated aliphatic aldehydes reveals carbon number-specific molecules involved in pulmonary toxicity. Chem Res Toxicol. 2014 Aug 18;27(8):1362-70.